Skip Navigation

Medical University | MUSC Hospital | College of Medicine | Directory

Department of Psychiatry and Behavioral Sciences

MUSC logo

ART


Department of Psychiatry

History of the Department

Patient Services

Divisions & Programs

Education & Training

Faculty

Continuing Education

Philanthropy & Giving

Contact Us

Directions

About Charleston

Intranet

Visit us on Facebook Twitter  You Tube
 




 

   

   

   

  
 
 

 

 


DART
————
Resident Research Training Program for Physician-Scientists

DART Home 

DART ResidentsSeminar Schedule

Application Information

Publications-Presentations

Newsletter

Brochure

Research Resources

DART SUMMER FELLOWSHIP PROGRAM


DART TRAINEE PUBLICATIONS, 2006-2010
(alphabetically according to trainee name)

Trainee Name

Publications

Barth, KS

Barth K.S., Becker W.C., Wiedemer N., Mavandadi S., Oslin D.W., Meghani S.H., & Gallagher R.M. (in press). Association between urine drug test results and treatment outcome in high-risk chronic pain patients on opioids.  Journal of Addiction Medicine.

Barth K.S., Hines S., & Albanese R.P. (2006). Permanent neurologic damage from chronic gamma hydroxybutyrate abuse. American Journal on Addiction, 15(6): 483-484.

Barth K.S. & Malcolm R.J. (2010).  Disulfiram: an old therapeutic with new applications. CNS Neurological Disorders- Drug Targets, 9(1): 5-12.

Becker W., Fiellin D., Gallagher R.M., Barth K.S., & Oslin D. (2009). The association between chronic pain and prescription drug abuse in veterans. Pain Medicine, 10(3): 531-536.

Becker W.C., Meghani S.H., Barth K.S., Wiedemer N., & Gallagher R.M.(2009).  Characteristics and outcomes of patients discharged from the Opioid Renewal Clinic at the Philadelphia VA Medical Center. American Journal of Addiction,18(2): 135-139.

Snarr B.S., Phan S.V., Garner A., VandenBerg A.M., & Barth K.S. (2010).  Symptomatic bradycardia with oral Aripiprazole and oral Ziprasidone. Annals of Pharmacotherapy, 44(4): 760-763.

Clark, DD

Deas D., & Clark A. (2008). Evidence-based treatments for alcohol use disorders in adolescents. Pediatrics, 121: S348-S354.

Deas D., & Clark A. (2009). Current state of treatment for alcohol and other drug use disorders in adolescents. Alcohol Research and Health, 32(1): 76-82.

Deas D., & Clark A. (2009). Youth binge drinking: Progress made and remaining challenges. Journal of the American Academy of Child & Adolescent Psychiatry, 48(7): 679-680.

Deas D., Clark A., & Johnson N. (under review). Patterns of alcohol and drug use: Racial differences among college students. American Journal on Addiction.

Fox, J

Aravapalli A., Fox J., & Lazaridis C. (2009). Cerebral fat embolism and the "starfield" pattern: a case report. Cases Journal, 2: 212.

Goddard, ER

Goddard E.R., Barth K., Lydiard R.B. (2007). Disorders which frequently overlap with irritable bowel syndrome: Can a shared neurobiology explain their association? Primary Psychiatry, 14(4): 69-73.

Goddard E., Barth K.S., & Lydiard R.B. (2007) Neurobiology of Irritable Bowel Syndrome and Psychiatric Disorders: An Overlap. Primary Psychiatry, 14(4): 69-73.

Goddard E., & Lydiard R.B. (2006). Stress and fitness. Oblique Magazine, 2: 12-13.

Goddard E., & Lydiard R.B. (under review). Psychosis in a Niacin Deficient Adolescent.

Goddard E.R., Yeatts S., Haman K., & Lydiard R.B. (under review). Anxiety sensitivity index predicts number of reported adverse events. Anxiety and Depression.

Herbsman, T

Herbsman T., Avery D., Holt R., Ramsey D., Holtzheimer P., Wadjik C., George M.S., & Nahas Z. (2009). More lateral and anterior prefrontal coil location is associated with better rTMS antidepressant response. Biological Psychiatry, 66(5): 509-515. PMID: 19545855.

Herbsman T., Foster L., Molnar C., Dougherty R., Ramsey D., Morgan P., George M.S., & Nahas Z., (2009). Motor threshold in transcranial magnetic stimulation: The impact of white matter fiber orientation and scalp-to-cortex distance. Human Brain Mapping, 30(7): 2044-2055. PMID: 18973261

Herbsman T., & Nahas Z. (2010). White matter correlates of clinical function in schizophrenia using diffusion tensor imaging. Schizophrenia Research, 116(1): 99-100. PMID: 19854619

Kruesi M., Laken S., Johnson K., Herbsman T., Morgan P., Christie D., & Kozel F. (under review). Functional neuroanatomy of lying differs in conduct disorder youth. Biological Psychiatry.

Nahas Z., Burns C., Foust M.J., Short B., Herbsman T., & George M.S. (2006). Vagus nerve stimulation (VNS) for depression: What do we know now and what should be done next? Current Psychiatry Report, 8(6):445-451.

Pincus D., Kose S., Arana A., Johnson K., Morgan P., Borckhardt J., Herbsman T., Hardaway F., George M.S., Panksepp J., & Nahas Z. (under review). Inverse effects of Oxytocin on attributing mental activity to others in depressed and healthy subjects: A double-blind placebo controlled fMRI Study. American Journal of Psychiatry.

Holes-Lewis, K

Holes-Lewis, K., Hakim, S., Rehman, F., Nabi, H., & Uhde, T. (under review). CCK-induced gall bladder hyperkinesia: An indication for cholecystectomy and brain-GI connectivity research. Journal of Nuclear Medicine.

Holes-Lewis, K.A.,Richard, E, & Brawman-Mintzer,O. (in press). Clinical Trials-A Challenge by Design. In: T. Uhde (Ed.), Treatment of Anxiety and Depression. Clinical Publishing Ltd.

Holt, RL

Holt R.L. (2008). Pinel and the pendulum. In P. Rudnytsky & R. Charon (eds), Psychoanalysis and Narrative Medicine. SUNY Press.

Holt R.L., Montesinos S., & Christensen R.C. (2007). Physical and sexual abuse history in women seeking treatment at a psychiatric clinic for the homeless. Journal of Psychiatric Practice, 13(1): 58-60.

Nahas Z., Kozel F.A., Molnar C., Holt R., Ricci R., Johnson K., Koola J., George M. (2007). Methods for administering transcranial magnetic stimulation. In M.S. George & R.H. Belmaker (eds), Transcranial Magnetic Stimulation in Clinical Psychiatry. New York: American Psychiatric Publishing, Inc.

Lewis, A

Gray, K.M, Carpenter, M.J, Baker, N.L, Lewis, A.L., & Upadhyaya, H.P. (in press). Attention-Deficit/Hyperactivity Disorder (ADHD) confounds nicotine withdrawal self-report in adolescent smokers. American Journal of Addictions.

Gray, K.M., Carpenter, M.J., Baker, N.L., Hartwell, K.J., Lewis, A.L., Hiott, D.W., Deas, D., Upadhayaya, H.P. (under review). Bupropion SR and contingency management for adolescent smoking cessation: A randomized, double-blind, placebo-controlled trial. Journal of Child and Adolescent Psychiatry.

Lewis, A. (2009). Malignant catatonia: B12 deficiency, NMS, or both. Journal of Psychiatric Practice. 15(5): 415-422. PMID: 19820558

Payne, RA

Back, S.E. & Payne, R.A., (2009). Gender and prescription opioids. In K.T. Brady, S.E. Back, & S. Greenfield (eds.), Women and Addiction: A Comprehensive Handbook (pp. 379-395). New York, NY: Guilford Press.

Back, S.E., Payne, R.A., Simpson, A.N., & Brady, K.T. (under review). Gender and prescription opioids: Findings from the National Survey on Drug Use and Health. Addictive Behaviors.

Back, S.E., Payne, R.A., Waldrop, A.E., Smith, A., Reeves, S., & Brady, K.T. (2009). Prescription opioid aberrant behaviors: A pilot study of gender differences. Clinical Journal of Pain, 25: 477–484. PMID: 19542794

Back, S.E., Payne, R.A., Wahlquist, A.H., Carter, R.E., Stroud, Z., Haynes, L., Hillhouse, M., Brady, K.T., & Ling, W. (under review). Comparative profiles of men and women with opioid dependence: Results from a national multisite clinical trial. Journal of Substance Abuse Treatment.

Payne, R.A. (2009).  Improving lives, restoring dreams:  My decision to become an addiction psychiatrist.  AAAP News, 25(1): 6. 

Payne, R.A., Back, S.E., Wright, T., Hartwell, K., & Brady, K.T. (2009) Alcohol dependence in women: Comorbidities can complicate treatment. Current Psychiatry, 8(6): 52-59.

Saladin, M. E., Back, S. E., & Payne, R. (2009). Posttraumatic stress disorder and substance use disorder comorbidity. In R. Ries, D. Fiellin, S. Miller, & R. Saitz (eds.) Principles of Addiction Medicine (4th ed., pp 1249-1262). Baltimore, MD: Lippincott Williams & Wilkins.

Verduin M.L., Payne R.A., McRae A.L., Back S.E., Simpson S.A., Sarang T.Y., & Brady K.T. (2007). Assessment of club drug use in treatment-seeking sample of individuals with marijuana dependence.  American Journal of Addiction, 16: 142-143. 

Reusche, C

Reusche, C., Kennedy, C., & Borckardt, J., (under review). Combating stigma in mental health: The effects of ethnicity and education on mental health literacy. American Journal of Psychiatry.

Tolliver, BK

Brady K.T., Tolliver B.K., & Verduin M.L. (2007). Alcohol use and anxiety: Diagnostic and management issues. American Journal of Psychiatry, 164: 217-221.

Brady K.T., Verduin M.L., & Tolliver B.K. (2007). Treatments of patients comorbid for addiction and other psychiatric disorders. Current Psychiatry Reports, 9(5): 374-380.

Gao K., Chan P., Verduin M.L., Kemp D.E., Tolliver B.K., Ganocy S.J., Bilali S., Brady K.T., Findling R.L., and Calabrese J.R. (in press). Independent predictors for lifetime and recent substance use disorders in patients with rapid cycling bipolar disorder:  Focus on anxiety disorders. American Journal on Addictions.

Gao K., Tolliver B.K., Kemp D.E., Verduin M.L., Ganocy S.J., Bilali S., Brady K., Shim S.S., Findling R.L., & Calabrese J.R. (2008). Differential interactions between comorbid anxiety and substance use disorder in rapid cycling Bipolar I or II disorder. Journal of Affective Disorders, 110: 167-173.

Gao K., Verduin M.L., Kemp D.E., Tolliver B.K., Ganocy S.J., Elhaj O., Brady K. Findling R.L., Calabrese J.R. (2008). Clinical correlates of patients with rapid cycling bipolar disorder and a recent history of substance use disorder: A subtype comparison. Journal of Clinical Psychiatry, 69: 1057-1063.

Hartwell K.J., Tolliver B.K., and Brady K.T. (2009). Biological commonalities between mental illness and addiction.  Primary Psychiatry 16(8): 33-39.

McRae A.L., Verduin M.L., Tolliver B.K., Anderson S.J., & Brady K.T. (under review). Efficacy and safety of aripiprazole in patients with substance use disorders.

McRae A.L., Verduin M.L., Tolliver B.K., Carter R.E., Wahlquist A.E., Brady K.T., Cluver J.S., Anderson S.J. (2009). An open-label trial of aripiprazole treatment in dual diagnosis individuals: Safety and efficacy. Journal of Dual Diagnosis, 5(1): 83-96.

Mendelson J.E., Tolliver B.K., Delucchi K.L., Baggott M.J., Flower K., Harris C.W., Galloway G.P., & Berger S.P. (2010). Capsaicin, an active ingredient in pepper sprays, increases the lethality of cocaine.  Forensic Toxicology, 28: 33-37.

Sullivan M.A., Nace E.P., Birkmayer F., Galanter M,. Frances R.J., Fromson J.A., Levin F.R., Lewis C., Suchinsky R.T., Tamerin J.S., Tolliver B.K., Westermeyer J. (2008). Uses of coercion in addiction treatment: Clinical aspects. American Journal on Addiction, 17(1): 36-47.

Tolliver B.K. (in press). Bipolar disorder and comorbid substance use disorders:  pearls and perils in clinical management.  Current Psychiatry.

Tolliver B.K., McRae-Clark A.L., Saladin M., Price K.L., DeSantis S.M., Simpson A.N., Baker N.L., & Brady K.T. (2010). Determinants of cue-elicited craving and physiologic reactivity in methamphetamine-dependent subjects in the laboratory.  American Journal of Drug and Alcohol Abuse, 36: 106-113.

Tolliver B.K., McRae A.L., Sonne S., & Brady K.T. (2009). Safety and tolerability of acamprosate in alcohol-dependent individuals with bipolar disorder: An open label pilot study. Addictive Disorders and their Treatment, 8, 33-38.

Tolliver B.K., McRae A.L., Verduin M.L., Anderson S.J., & Brady K.T. (2008). Reversible elevation of triglycerides in dual diagnosis patients with aripiprazole: A case series. Journal of Clinical Psychopharmacology, 28(4): 464-467.

Vedeniapin, A

Boutrous N.N., Brockhaus-Dumke A., Gjini K., Vedeniapin A., Elfakhani M., Burroughs S., et al. (2009). Sensory-gating deficit of the N100 mid-latency auditory evoked potential in medicated schizophrenia patients. Schizophrenia Research, 113(2-3): 339-346.

Uhde TW, Cortese BM, Vedeniapin A. (2009). Anxiety and sleep problems: emerging concepts and theoretical treatment implications. Curr Psychiatry Rep, 11(4): 269-76.

Vedeniapin, A. & Hegarty, J. (under review). Successful treatment of NMS on high potency antipsychotic therapy with ECT and quetiapine rechallenge. Progress in Neuro-Psychopharmacology & Biological Psychiatry.

DART TRAINEE PRESENTATIONS, 2006--2010
(alphabetically according to trainee name)

Trainee Name

Presentations

Barth, KS

Barth K.S. (2006). Permanent neurologic damage from chronic GHB abuse. Poster presented at the American College of Physicians National Meeting, Philadelphia, PA.

Barth K.S. (2006). Permanent neurologic damage from chronic GHB abuse. Paper presented at the Internal Medicine Grand Rounds, Medical University of South Carolina, Charleston, SC.

Becker W.C., Meghani S.H., Barth K.S., Wiedemer N., & Gallagher R.M. (2008). Brief report: Characteristics and outcomes of patients discharged from the opioid renewal clinic at the Philadelphia VA Medical Center. Presented at the American Academy of Pain Medicine Annual Meeting, Orlando FL.

Wiedemer N., Meghani S.H., Becker, W.C., Harden P.S., Barth K.S., & Gallagher R.M. (2008). Predictors of the resolution of aberrant drug behavior in a sample of patients treated in the Opioid Renewal Clinic at the Philadelphia VA Medical Center.  Presented at the American Academy of Pain Medicine Annual Meeting, Orlando FL.

Clark, A

Clark, A. (2008). Living in MySpace: Clinical Concerns for the Social Internet. Presented at the annual meeting of the American Academy of Child and Adolescent Psychiatry, Chicago, IL.

Clark A. (2009). Web 2.0: Cyberbullying to Cybersupport. Presented at the annual meeting of the American Academy of Child and Adolescent Psychiatry, Honolulu, HI.

Clark A., Deas D., Thomas S., & Anton R. (2009). Percent heavy drinking days predicts % CDT in alcohol dependent adolescents (2009). Presented at the annual meeting of the American Academy of Child and Adolescent Psychiatry, Honolulu, HI.

Clark A., Johnson N., Merrit C., & Deas D. (2008). Gender differences in risky behaviors among inpatient adolescents. Presented at the annual Meeting of the College on Problems of Drug Dependence, San Juan, Puerto Rico.

Clark, A., Merritt, C., Johnson, N., & Deas, D. (2008). Gender differences in risk behaviors among inpatient adolescents. Presented at the annual meeting of the College of Problems of Drug Dependence, San Juan, Puerto Rico.

Deas D., Merritt C., Johnson N., & Clark A. (2007) Risky behaviors among psychiatric inpatient adolescents. Presented at the annual meeting of the American College of Neuropsychopharmacology, Boca Raton, FL.

Johnson T., Clark A., Johnson N., Merritt C., & Deas D. (2007). Prevalence of risky behaviors among inpatient adolescents. Presented at the annual meeting of the American Academy of Child and Adolescent Psychiatry, Boston, MA.

Fox, J

Aravapalli A., Fox J., & Lazaridis C. (2009). Cerebral fat embolism and the ‘Starfield’ pattern.”  Presented a the South Carolina Medical Association Annual Meeting, Hilton Head, SC.

Fox J., Nahas Z., & George M.S. (2010).  Increased Treatment Resistance Is Associated With Greater Left Prefrontal Cortex Activation During A Verbal Working Memory Task.  To be presented at the Annual Biological Psychiatry meeting, New Orleans, LA.

Goddard, E

Emmanual N., Lydiard R.B., Goddard E.R., DeSantis S., Johnson M., Morton W.A., Czepowicz V.D., Brawman-Mintzer O., Book S.W., Rubey R.N., & Ballenger J.C. (2007). Eight week treatment study of Imipramine v. Pbo in Generalized Social Anxiety Disorder. Poster presented at the annual meeting of the Anxiety Disorder Association of America, St. Louis, Missouri.

Goddard E., Yeatts S., & Lydiard R.B. (2007). Anxiety sensitivity index (ASI) as a predictor of adverse events in a depressed population. Poster presented at the annual meetings of the Anxiety Disorders Association of America, St. Louis, MO.

Herbsman, T

Hajcak G., Takacs S., Anderson B., Borckardt J., Reeves S., Arana A., Herbsman T., Kose S., Uhde T., George M.S., & Nahas Z.  (2008).  Direct bilateral epidural prefrontal cortical electrical stimulation (EpCS) down- regulates amygdala-mediated emotional appraisal in treatment-resistant depression. Poster presented at the American College of Neuropsychopharmacology, Scottsdale, AZ.

Herbsman T., Avery D., Holt R., Ramsey D., Holtzheimer P., Wadjik C., Hardway F., Haynor D., George M.S., Nahas Z.  (2008). More lateral and anterior prefrontal coil location improves rTMS antidepressant response. Poster presented at the American College of Neuropsychopharmacology, Scottsdale, AZ.

Herbsman T., Birn R, Anderson B, Arana A, Pincus D, Panksepp J, Kalin N, George MS, & Nahas Z. (2009) Prefrontal Cortex Resting State Functional Connectivity: Implications for Neuromodulation Strategies in Depression. Poster presented at the American College of Neuropsychopharmacology, Hollywood, Florida.

Herbsman T., Molnar C., Horner M., Anderson B., Foster L., Ballenger J., George M.S., & Nahas Z. (2007). White matter correlates of clinical and  neurocognitive function in schizophrenia using diffusion tensor  imaging. Poster presented at the American College of Neuropsychopharmacology, Boca Raton, Florida.

Herbsman T., Molnar C., Horner M., Anderson B., Foster L., George M.S., & Nahas Z. (2008). White matter correlates of clinical and neurocognitive function in schizophrenia using diffusion tensor imaging. Poster presented at the annual meeting of the American Neuropsychiatric Association, Savannah, Georgia.

Herbsman T., Morgan P., Johnson K., Kose S., Arana A., Anderson B., Pincus D., George M.S., Panksepp J., & Nahas Z. (2008). Resting state BOLD activity in depression. Poster presented at the 63rd Annual Meeting of the Society of Biological Psychiatry, Washington, DC.

Kose S., Morgan P., Johnson K., Arana A., Anderson B., Pincus D., Herbsman T., George M.S., Panksepp J., & Nahas Z. (2008). Oxytocin for Treating Depression: A Double Blind Placebo Controlled Neuroimaging Study. Poster presented at the 63rd Annual Meeting of the Society of Biological Psychiatry, Washington, DC.

Holes-Lewis, K

Holes-Lewis K., Hakim S., Rehman F., Nabi H., & Uhde T. (2009). CCK-Induced Gall Bladder Hyperkinesia: An Indication for Cholecystectomy and Brain-GI Connectivity Research. Presented at the Annual meeting of the Society of Nuclear Medicine in Toronto, Canada.

Holt, RL

Holt R.L., Ossa K. (2006), Demographic differences in diagnosis of psychosis among psychiatric patients in South Carolina. Poster presented at the annual meeting of the Institute on Psychiatric Services, New York, NY.

Nahas Z., Molnar C., Ramsey C., Walker J., Koola J., Johnson K., Kozel F.A., Christie D., Holt R., Li X. et al. (2005). Interleaved TMSfMRI in schizophrenia: dysfunctional working memory network. Poster presented at the annual meeting of the American College of Neuropsychopharmacology, Waikoloa, HI.

Lewis, AL

Gray K.M., Carpenter M.J., Baker N.L., Lewis A.L., & Upadhyaya H.P. (2009).  Do adolescent smokers with attention-deficit/hyperactivity disorder (ADHD) have greater nicotine withdrawal? Presented at the annual meeting of the Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting, Dublin, Ireland.

Lewis A.L., Gray K.M., Baker N.L., Carpenter M.J., & Upadhayaya H.P. (2009). Getting off on a good foot: Does Abstinence on a predetermined quit date guarantee anything in adolescent smokers? Presented at the annual meeting of the American Academy of Child and Adolescent Psychiatry, Honolulu, HI.

Lewis A.L., Gray K., Carpenter M., Klintworth E., Leinbach A., & Upadhyaya H (2009). Attention-Deficit/Hyperactivity Disorder (ADHD) and nicotine withdrawal symptoms among treatment-seeking adolescent smokers. Poster presented at the annual meeting of College on Problems of Drug Dependence, Reno, NV.

Payne, RA

Back S.E., Payne R.A., Brady K.T., & Stroud Z. (2009). Gender differences in prescription opioid dependence: A pilot study.  Presented at the annual meeting of the College on Problems of Drug Dependence, Reno, Nevada.

Back S.E., Payne R.A., Simpson A.N., & Brady K.T. (2010). Predictors of prescription opioid non-medical use, abuse and dependence: Findings from the National Survey on Drug Use and Health. To be presented at the annual meeting of the College on Problems of Drug Dependence, Scottsdale, AZ.

Back S.E., Stroud Z.B., Payne R.A., Waldrop A.E., Smith A.R., Reeves S. & Brady K.T. (2009). The relationship between pain symptomatology and post-traumatic stress disorder. Presented at the annual meeting of the World Institute on Pain, New York, NY.

Back S.E., Waldrop A.E., Smith A., Reeves S., Hicks B., Payne R.A., & Brady K.T. (2007).  Correlates and gender differences of chronic pain patients using prescription opiates:  A pilot study. Paper presented at the annual meeting of the College on Problems of Drug Dependence, Quebec, Canada. 

Haynes L., Wahlquist A., Carter R., Back S., Payne R.A., & Hillhouse M. (2009). Gender differences at presentation for treatment-seeking opiate dependence. Presented at the annual meeting of the College on Problems of Drug Dependence, Reno, Nevada.

Payne R.A. (2009).  Prescription Pain Relievers:  For Pain or Pleasure?  PGY-IV Selected Presentation for Grand Rounds Series, Medical University of South Carolina, Charleston, SC.

Payne R.A., Back S.E., Clyde S., Waldrop A.E., & Brady K.T. (2008).  Gender differences in prescription opioid use and misuse among chronic pain patients.  Poster presented at the annual meeting of the College on Problems of Drug Dependence, San Juan, Puerto Rico.

Payne R.A., Back S.E., Clyde S., Waldrop A.E., & Brady K.T. (2008).  General anxiety disorder and risk of prescription opiate misuse among inpatients on a detoxification unit.  Poster presented at the annual meeting of the Anxiety Disorders Association of America, Savannah, GA.

Payne R.A., Back S.E., Waldrop A.E., Brady K.T.  (2007). Prescription opiate use among male and female inpatients on a detoxification unit:  A pilot study.  Poster presented at the annual meeting of the American Association for Addiction Psychiatry, San Diego, California.

Payne R.A., Back S.E., Waldrop A.E., & Brady K.T (2009). Gender differences in the prevalence of prescription opioid use among inpatients with substance use disorders.  Presented at annual meeting of the College on Problems of Drug Dependence, Reno, NV. 

Payne R.A., Back S.E., Waldrop A.E., & Brady K.T. (2009). Gender differences in chronic pain and prescription opioid use among substance abuse inpatients. Presented at the 2009 annual meeting of the World Institute on Pain, New York, NY.

Reusche, C

Reusche, C., Kennedy, C., & Borckardt, J. (2010). Combating stigma in mental health: The effects of ethnicity and education on mental health literacy. To be presented at the annual American Psychiatric Association, New Orleans, LA.

Tolliver, BK

Prisciandaro J.J., Brown D.G., Brady K.T., & Tolliver B.K.  (2010). Risk taking in alcohol-dependent individuals with bipolar disorder is associated with dependence severity but not amount of recent alcohol use.  To be presented at the Research Society on Alcoholism Annual Meeting, San Antonio.

Tolliver, B.K. (2008). Clinical dilemmas in the treatment of dual diagnosis patients. Case Conference with Dr. Mark A. Frye, Dr. Daniel Hall-Flavin, and Dr. Anya Yurchenko, Mayo Clinic. Paper presented at the American Psychiatric Association Annual Meeting, Washington DC.

Tolliver, B.K. (2010). Dysregulation of glutamate neurotransmission as a potential therapeutic target in bipolar disorder and comorbid alcohol dependence: A review of current evidence. Paper presented at the International Society for Bipolar Disorders Annual Meeting, Sao Paulo.

Tolliver B.K., LaRowe S.D., Chapman E., Garrett M., Price K.L., Saladin M.E., McRae-Clark A.L., & Brady K.T. (2010). Pronounced attentional bias in methamphetamine-dependent subjects upon methamphetamine cue exposure: relationship to craving. To be presented at the College on Problems of Drug Dependence Annual Meeting, Scottsdale, AZ.

Tolliver B.K., McRae A.L., Anderson S.J., & Brady K.T. (2006). The use of acamprosate in alcohol-dependent individuals with comorbid bipolar affective disorders. Presented at the American Psychiatric Institute for Research and Education (APIRE) Colloquium for Junior Investigators, American Psychiatric Association, Annual Meeting, Toronto, Canada.

Tolliver B.K., McRae A.L., Saladin M., Price K., Chapman E., Tyson C., & Brady K.T. (2008). Methodological factors in measuring induction and extinction of cue-induced craving in human methamphetamine users.  Presented at the American College of Neuropsychopharmacology Annual Meeting, Scottsdale.

Tolliver B.K., McRae A.L., Sonne S.C., & Brady K.T. (2007). Safety and tolerability of Acamprosate in alcohol-dependent individuals with comorbid bipolar disorder: An open label pilot study. Presented at the American College of Neuropsychopharmacology Annual Meeting, Boca Raton.

Tolliver B.K., McRae A.L., Verduin M.L., Anderson S.J., Herrin A., Carter R., & Brady K.T. (2007). A comparison of the efficacy of aripiprazole on psychiatric and substance use outcomes in bipolar and schizophrenic patients.  Presented at the College on Problems of Drug Dependence Annual Meeting, Quebec City.

Tolliver B.K., Saladin M., McRae-Clark A.L., Price K.L., Chapman E., & Brady K.T. (2009). Predictors of cue-induced craving for methamphetamine in subjects with recent methamphetamine abuse or dependence.  Presented at the College on Problems of Drug Dependence Annual Meeting, Reno.

Tolliver B.K., Waldrop A.E., & Brady K.T. (2008).  The Balloon Analogue Risk Task as a measure of impulsivity in alcohol-dependent individuals with bipolar disorder.  Presented at the College on Problems of Drug Dependence Annual Meeting, San Juan, Puerto Rico.

Verduin M.L., McRae A.L., Tolliver B.K., Herrin A., Carter R.E., & Brady K.T. (2007). Efficacy of aripiprazole in patients with substance use disorders.  Presented at the College on Problems of Drug Dependence Annual Meeting, Quebec City.

Vedeniapin, A

Vedeniapin A. Bixler E., Vela-Bueno A., & Vgontzas A. (2008). Gender effect on the sleep slow EEG frequencies after partial sleep restriction. Presented at the Sleep conference, Baltimore, MD.

Vedeniapin A., Elfakhani M., Burroughs S., & Boutros N.N. (2008) Perturbations in positive middle latency auditory evoked potentials in relation to hallucinatory behavior in schizophrenia. Presented at the EEG and Clinical Neuroscience Society Conference, Frankfurt, Germany.

Vedeniapin A., Elfakhani M., Burroughs S., & Boutros N.N. (2009). Perturbations in positive middle latency auditory evoked potentials in relation to hallucinatory behavior in schizophrenia. Presented at the South Carolina Psychiatric Association Conference, Myrtle Beach, SC.

About the Division
CND Faculty & Staff
Publications
Currently Recruiting Studies
Resources
Seminar Schedules
Addiction Psychiatry Fellowship
BIRCWH
CTN
DART
NIDA K12
SCOR
WRC
Contact Us




Aimee L. McRae-Clark,
PharmD, BCPP

Director,
Clinical Neuroscience Division

Professor, 
Department of
 Psychiatry and Behavioral Sciences